Osteoporosis Bone Disease Quiz

The statement is true because a T-score is a measure of how many standard deviations a person's bone mineral density is from the mean of healthy young white women. Osteoporosis is defined as a T-score of at least -2.5 standard deviations below the mean, while osteopenia is defined as a T-score between -2.5 and -1.0 standard deviations below the mean. Therefore, the statement accurately describes the definitions of osteoporosis and osteopenia based on T-scores.

Lab tests are not very effective in diagnosing osteoporosis itself because they do not directly measure bone density. However, they can be helpful in identifying underlying conditions or factors that may contribute to bone loss, such as hyperparathyroidism, hyperthyroidism, hypogonadism, cancer, or low levels of vitamin D. These secondary causes of bone loss can be identified through lab tests, allowing for appropriate treatment and management. Therefore, lab tests have little value in diagnosing osteoporosis but can be beneficial in identifying secondary causes of bone loss.

Under normal circumstances, the human skeleton undergoes a dynamic process of bone remodeling. Osteoclasts, which are involved with resorption, play a key role in this process. Resorption refers to the breakdown of bone tissue.

While her age is less than 65...she has risk factors. Her race, having a first degree relative, and coffee consumption increase her risk.

Kidney stones may occur with the use of calcium oxalate. Calcium oxalate is a common type of kidney stone that forms when there is too much oxalate and calcium in the urine. Oxalate is a naturally occurring substance found in many foods, and when it combines with calcium in the urine, it can form crystals that can eventually develop into kidney stones. Therefore, the presence of calcium oxalate in the urine can increase the risk of kidney stone formation.

Chronic bisphosphonate therapy has been associated with the development of osteonecrosis in the jaw. This condition, known as bisphosphonate-related osteonecrosis of the jaw (BRONJ), is characterized by the death of bone tissue in the jaw. Dentists are often the first to notice this condition as they may observe exposed bone, non-healing ulcers, or infections in the mouth. Therefore, it is important for patients on long-term bisphosphonate therapy to inform their dentists and undergo regular dental examinations to monitor for any signs of jaw osteonecrosis.

All current national guidelines for BMD testing agree routine screening should occur for women aged 65 or older. This means that it is recommended for women who are 65 years old or above to undergo routine screening for BMD (bone mineral density). This screening helps to assess the strength and health of the bones, and can help in early detection and management of osteoporosis or other bone-related conditions. Regular screening is important for older women as they are at a higher risk of developing bone-related issues.

Patients with vertebral fractures may experience chronic pain, height loss, and kyphosis. Kyphosis is a condition characterized by an excessive forward curvature of the upper spine. This can lead to a hunched posture and restricted lung function, causing restrictive lung disease.

Calcium Carbonate contains the highest elemental calcium among the given options. Calcium carbonate is a common form of calcium supplement, often used to treat calcium deficiency. It contains 40% elemental calcium, which means that for every 1000 mg of calcium carbonate, 400 mg is actual calcium. Calcium carbonate is also widely available and affordable, making it a popular choice for calcium supplementation.

Some mild analgesic activity. Store in refrigerator when unopened, stable at room temp for 4 weeks.

Osteoporosis is a condition characterized by weak and brittle bones. The risk factors for osteoporosis include being White or Asian, having had a hysterectomy, having a small body frame, eating prednisone like candy for more than 3 months, and having a poor diet. Being White or Asian is a risk factor because individuals from these ethnic backgrounds tend to have lower bone density. Having had a hysterectomy can increase the risk of osteoporosis due to hormonal changes. A small body frame means less bone mass, which can make bones more susceptible to osteoporosis. Eating prednisone, a medication known to weaken bones, for an extended period can also increase the risk. Finally, a poor diet lacking in essential nutrients for bone health can contribute to osteoporosis.

Bone strength is determined by two main factors: bone mineral density (BMD) and bone quality. BMD refers to the amount of minerals, such as calcium, present in the bone, which directly affects its strength. However, bone quality also plays a crucial role in determining bone strength. Bone quality refers to the structure and integrity of the bone, including factors such as bone architecture, microstructure, and collagen content. Both BMD and bone quality are important components of bone strength, making the answer "BMD and bone quality" correct.

Zolendronate is given as an IV infusion once every year. This dosing schedule is supported by the statement that the most common adverse events include myalgia, headache, arthralgia, and pain in extremities. These adverse events are typically associated with the use of Zolendronate and the once-yearly dosing helps to minimize their occurrence while still providing the desired therapeutic effects.

During menopause, women experience a decrease in estrogen levels, which can lead to accelerated bone loss. This is why osteoporosis is more common in women. However, osteoporosis can also develop from secondary causes such as hypogonadism, which is a condition where the body doesn't produce enough sex hormones; glucocorticoid use, which refers to the long-term use of corticosteroids that can weaken bones; skeletal cancer, which can cause bone destruction; alcoholism, which can interfere with bone formation and increase the risk of fractures; and eating disorders, which can lead to malnutrition and decreased bone density.

The NOF guidelines for BMD treatment include a T-score below -1.0 by central DXA and FRAX risk probability greater than or equal to 20% or greater than or equal to 3% for hip fracture. This means that if a patient has a T-score below -1.0 and a FRAX risk probability of 3% or higher for hip fracture, they would meet the criteria for BMD treatment according to the NOF guidelines.

Peripheral BMD measurements cannot be used for diagnosis because they do not correlate with central measurements (such as the hip). However, they are useful in identifying patients who are candidates for central DXA.

SERMS can cause hot flashes and leg cramps.

Aromatase inhibitors, IM medroxyprogesterone, immunosuppressive medications (such as cyclosporine), and excessive levothyroxine doses are all associated with bone loss. Aromatase inhibitors are commonly used in the treatment of breast cancer and can cause bone loss by inhibiting estrogen production. IM medroxyprogesterone is a hormonal contraceptive that can also lead to bone loss. Immunosuppressive medications, like cyclosporine, are used to prevent rejection in organ transplant patients and can contribute to bone loss. Excessive doses of levothyroxine, a medication used to treat hypothyroidism, can also have negative effects on bone health.